Related content

A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients with Metastatic or Advanced, Locally Recurrent Head and Neck Cancers

By Zhang Jingsong   Lee Julia   Urba Susan   Foster Jared   Worden Francis  

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 910-916

Informa Healthcare

Access to resources Recommend Favorite

First-Line Chemotherapy with Paclitaxel and Platinum for Advanced and Recurrent Cancer of the Cervix-A Phase II Study

By Piver M.S.   Ghamande S.A.   Eltabbakh G.H.   O'Neill-Coppola C.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 334-337

Elsevier

Access to resources Recommend Favorite

Intermittent Hormone Therapy in Prostate and Breast Cancers

By Stoll B.A.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2415-2416

Elsevier

Access to resources Recommend Favorite

Part II: Testicular cancer-management of advanced disease

By Jones R.H.   Vasey P.A.  

Lancet Oncology, Vol. 4, Iss. 12, 2003-12 ,pp. : 738-747

Elsevier

Access to resources Recommend Favorite

Chemotherapy plus Sequential Hormonal Therapy for Advanced and Recurrent Endometrial Carcinoma: A Phase II Study

By Pinelli D.M.   Fiorica J.V.   Roberts W.S.   Hoffman M.S.   Nicosia S.V.   Cavanagh D.  

Gynecologic Oncology, Vol. 60, Iss. 3, 1996-03 ,pp. : 462-467

Academic Press

Access to resources Recommend Favorite